Viewing StudyNCT01705691

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 1:00 AM
Last Modification Date: 2024-10-26 @ 10:57 AM
Study NCT ID: NCT01705691
Status: COMPLETED
Last Update Posted: 2021-10-06
First Post: 2012-10-08
Brief Title: Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by AC in Women With Locally Advanced HER2-Negative Breast Cancer
Sponsor: NSABP Foundation Inc
Organization: NSABP Foundation Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
HER2-negative Breast Cancer
Breast Cancer
Keywords: